Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction
dc.contributor.author | Temiz, Ahmet | |
dc.contributor.author | Gazi, Emine | |
dc.contributor.author | Gungor, Omer | |
dc.contributor.author | Barutcu, Ahmet | |
dc.contributor.author | Altun, Burak | |
dc.contributor.author | Bekler, Adem | |
dc.contributor.author | Binnetoglu, Emine | |
dc.date.accessioned | 2025-01-27T20:52:00Z | |
dc.date.available | 2025-01-27T20:52:00Z | |
dc.date.issued | 2014 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Background: Platelet-to-lymphocyte ratio (PLR) is a new prognostic marker in coronary artery disease. We aimed to evaluate the relationship between PLR and in-hospital mortality in patients with ST-elevated acute myocardial infarction (AMI). Material/Methods: The present study included 636 patients with ST-elevated AMI. The study population was divided into tertiles based on their admission PLR. Patients having values in the third tertile was defined as the high PLR group (n=212) and those having values in the lower 2 tertiles were defined as the low PLR group (n=424). Results: Risk factors of coronary artery disease and treatments administered during the in-hospital period were similar between the groups. Male patient ratio was found to be lower in the high PLR group (73% vs. 82.8%, p=0.004). In-hospital mortality was increased in the high PLR group when compared to the low PLR group (12.7% vs. 5.9%, p=0.004). The PLR > 144 was found to be an independent predictor of in-hospital cardiovascular mortality (HR: 2.16, 95% CI: 1.16-4.0, p=0.014). Conclusions: This study showed that PLR is an independent predictor of cardiovascular mortality in patients with ST-elevated AMI. | |
dc.identifier.endpage | 665 | |
dc.identifier.issn | 1643-3750 | |
dc.identifier.pmid | 24751474 | |
dc.identifier.scopus | 2-s2.0-84899132478 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 660 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/25620 | |
dc.identifier.volume | 20 | |
dc.identifier.wos | WOS:000334938700001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Int Scientific Information, Inc | |
dc.relation.ispartof | Medical Science Monitor | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | Myocardial Infarction | |
dc.subject | Hospital Mortality | |
dc.subject | Platelet/Lymphocyte Ratio | |
dc.title | Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction | |
dc.type | Article |